Rac1 mediates cadherin-11 induced cellular pathogenic processes in aortic valve calcification.
Rac1 mediates cadherin-11 induced cellular pathogenic processes in aortic valve calcification.
复制标题
DOI:
10.1016/j.carpath.2022.107414
复制
发表时间:
2022-05
期刊:
影响因子:
--
通讯作者:
Butcher JT
中科院分区:
文献类型:
--
作者:
Vaidya KA;Donnelly MP;Mahmut A;Jang JW;Gee TW;Aibo MI;Bossong R;Hall C;Samb S;Chen J;Butcher JT
Calcific aortic valve disease (CAVD), a major cause for surgical aortic valve replacement, currently lacks available pharmacological treatments. Cadherin-11 (Cad11), a promising therapeutic target, promotes aortic valve calcification in vivo, but direct Cad11 inhibition in clinical trials has been unsuccessful. Targeting of downstream Cad11 effectors instead may be clinically useful; however, the downstream effectors that mediate Cad11-induced aortic valve cellular pathogenesis have not been investigated. Immunofluorescence of calcified human aortic valves revealed that GTP-Rac1 is highly upregulated in calcified leaflets and is 2.15 times more co-localized with Cad11 in calcified valves than GTP-RhoA. Using dominant negative mutants in porcine aortic valve interstitial cells (PAVICs), we show that Cad11 predominantly regulates Runx2 nuclear localization via Rac1. Rac1-GEF inhibition via NSC23766 effectively reduces calcification in ex vivo porcine aortic valve leaflets treated with osteogenic media by 2.8-fold and also prevents Cad11-induced cell migration, compaction, and calcification in PAVICs. GTP-Rac1 and Trio, a known Cad11 binding partner and Rac1-GEF, are significantly upregulated in Nfatc1Cre;R26-Cad11Tg/Tg (Cad11 OX) mice that conditionally overexpress Cad11 in the heart valves by 3.1-fold and 6.3-fold, respectively. Finally, we found that the Trio-specific Rac1-GEF inhibitor, ITX3, effectively prevents Cad11-induced calcification and Runx2 induction in osteogenic conditions. Here we show that Cad11 induces many cellular pathogenic processes via Rac1 and that Rac1 inhibition effectively prevents many Cad11-induced aortic disease phenotypes. These findings highlight the therapeutic potential of blocking Rac1-GEFs in CAVD.
登录
查看更多内容
影响因子:
4.9
作者:
Abreu, Joana R. F.;Dontje, Wendy;Tak, Paul P.
通讯作者:
Tak, Paul P.
影响因子:
--
作者:
Marei H;Malliri A
通讯作者:
Malliri A
DOI:
10.1083/jcb.201604015
发表时间:
2016-11-21
期刊:
The Journal of cell biology
影响因子:
--
作者:
Martin E;Ouellette MH;Jenna S
通讯作者:
Jenna S
影响因子:
3
作者:
Duan, Bin;Hockaday, Laura A.;Butcher, Jonathan T.
通讯作者:
Butcher, Jonathan T.
DOI:
10.1073/pnas.1019437108
发表时间:
2011-05-17
影响因子:
11.1
作者:
Chang, Sook Kyung;Noss, Erika H.;Brenner, Michael B.
通讯作者:
Brenner, Michael B.